Get started
Author

Ramkumar Subramanian

Observed name: Subramanian, Ramkumar
Observed institution: Galderma (Switzerland)
ORCID: 0009-0001-0060-9540
Observed ORCID: 0009-0001-0060-9540
OpenAlex ID: A5037857679
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany
2024 · Nicholas Durno, Pablo Arija, et al. · Journal of Dermatological Treatment · 6
PDF
Comparing the Efficacy and Safety of Nemolizumab Versus Anti-interleukin Monoclonal Antibody Therapies in Combination with Topical Treatments for Moderate-to-Severe Atopic Dermatitis Using Network Meta-analysis
2026 · Andrew E. Pink, John Houghton, et al. · Dermatology and Therapy · 2
PDF
Nemolizumab Versus Dupilumab in the Treatment of Prurigo Nodularis: Systematic Literature Review and Network Meta-analysis
2026 · Gil Yosipovitch, Katarzyna Borkowska, et al. · Dermatology and Therapy · 1
PDF
Development of a Conceptual Disease Model of Atopic Dermatitis Using Data from the Phase 3 ARCADIA 1 Trial
2026 · Jonathan I. Silverberg, Patrick Daniele, et al. · Dermatology and Therapy
PDF
Patient preferences for prurigo nodularis treatment: a discrete choice experiment
2026 · Anthony Bewley, Sarina Elmariah, et al. · Journal of Dermatological Treatment
Patient preferences for prurigo nodularis treatment: a discrete choice experiment
2026 · Anthony Bewley, Sarina Elmariah, et al. · Figshare
A Conceptual Disease Model of Symptoms and Impacts in Adults with Prurigo Nodularis: A Qualitative and Literature-Informed Study
2026 · Shawn G. Kwatra, Danielle Rodriguez, et al. · Dermatology and Therapy
PDF
691 - Understanding patient and physician preferences when choosing between biologic and oral systemic treatment options for moderate-to-severe atopic dermatitis: a discrete choice experiment
2024 · Jorge Puelles, Pablo Arija, et al. · British Journal of Dermatology
Works count: 9
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type